Details for 2020724301

Up to date per 23.05.2026

Actions

Title / Product Name

MIRIKIZUMAB ZUR VERWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG VON MORBUS CROHN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020724301

EP Publication Number

3958897

E-Number

1918838

Language

PCT Number

US20028273

Publication Date

02.03.2022 A

06.05.2026 B1

Registration Date

06.05.2026

AT Publication Date

15.05.2026

Application Date

15.04.2020

Registration Number

Priorities

22.04.2019

201962836910 P

IPC

C07K 16/24 20060101AFI20240322BHEP

Maximum Duration of Protection

15.04.2040

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

No representatives present

Inventor

FRIEDRICH, Stuart Williamc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

POLLACK, Paul Frederickc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

TUTTLE, Jay Lawrencec/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

Information about Fees